A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

Phase

N/A

Condition

Dementia

Memory Loss

Progressive Supranuclear Palsy

Treatment

LEGSys

PAMSys

Clinical Study ID

NCT05956834

IRB00341607

Ages 40-89
All Genders

Study Summary

The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter study design and to follow each of them for 12 months.

The secondary objective of this study is to develop a robust solution for multi-modal remote monitoring of motor symptoms and function in PSP that can be applied to other Frontotemporal lobar degeneration (FTLD) syndromes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Clinical diagnosis of possible or probable PSP as defined by the 2017 MDS criteria
Fluent in reading and speaking English and capable of providing informed consentbased on the principal investigator's judgement
Able to walk 10 feet unassisted at the time of initial enrollment
Must have a caregiver or study partner who is willing and able to assist with allstudy-related procedures

Exclusion

Exclusion Criteria:

Any neurological, medical, or psychiatric condition that would precludeparticipation in study activities based on the investigator's judgment.
A history of frequent falls defined as more than 5 falls per month, or who require awalker to ambulate safely at baseline will not be eligible to participate in thestudy.

Study Design

LEGSys

July 28, 2023

December 30, 2026

Study Description

The goal of this project is to develop a robust multi-modal platform for remote monitoring of motor symptoms and cognitive function in FTLD syndromes using wearable sensors and mobile health technology to assess speech, motor, and cognitive functions. The solution will be validated in Progressive Supranuclear Palsy (PSP) by collecting longitudinal data from 60 PSP individuals with PSP. Enrollment will take place over a period of 24 months, though each participant will only be followed for 12 months for data collection. The participants will consist of adult volunteers from two leading CurePSP Centers of Care located at the Atypical Parkinsonism Center at Johns Hopkins Hospital in Baltimore, MD and Massachusetts General Hospital (MGH) in Boston, MA.

Connect with a study center

Johns Hopkins School of Medicine
Baltimore, Maryland 21093
United States
Active - Recruiting
Massachusetts General Hospital
Boston, Massachusetts 02114
United States
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.